BLAIR GEHO W has a total of 14 patent applications. Its first patent ever was published in 1986. It filed its patents most often in United States, Australia and Denmark. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are LIPOSOME TECHNOLOGY INC, MENDELL CO INC EDWARD and BIOGLAN IRELAND R & D LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | Denmark | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Finland | 1 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Biotechnology | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Unspecified technologies | |
#3 | Unspecified technologies | |
#4 | Specific use of cosmetics | |
#5 | Therapeutic chemical compounds | |
#6 | Foods | |
#7 | Peptides | |
#8 | Special foods | |
#9 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Lau John R | 12 |
#2 | Geho W Blair | 11 |
#3 | Geho Walter Blair | 3 |
#4 | Jacob Joseph | 1 |
Publication | Filing date | Title |
---|---|---|
US2010310599A1 | Orally bioavailable lipid-based constructs | |
US2010247625A1 | Orally bioavailable lipid-based constructs | |
US2012035105A1 | Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments | |
DK667289D0 | Gelkerner | |
US4942036A | Therapy by vesicle delivery to the hydroxyapatite of bone | |
AU5517286A | Antitoxin vaginal products and catamenials comprising ascorbic acid |